Appendix 2A - Application for quotation of securities Appendix 2A - Application for quotation of securities 1 / 6 Announcement Summary Entity name CLEO DIAGNOSTICS LTD Announcement Type New announcement Date of this announcement Monday August 24, 2026 The +securities to be quoted are:...
Application for quotation of securities - COV
Filed with ASX · · 6 pages · English
Release
Earlier from CLEO Diagnostics
- Notification of cessation of securities - COV
- Change in Director's Interest Notice
- Appendix 4E and 2026 Annual Report
- Appendix 4G and Corporate Governance Statement
- Quarterly activities and cashflow report
Later from CLEO Diagnostics
- Cleansing Notice
- Change of Director's Interest Notice x 4
- CLEO Receives First Batch of Commercial Test Kits
- CLIA Certified Lab selected - Pivotal US Clinical Validation
- Notice Required Under ASX Listing Rule 3.13.1
Follow CLEO Diagnostics into a list and get an email when it puts out news.
Follow CLEO Diagnostics